Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market ... PR Newswire UK (press release) The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constituting four of the global top 20 best-selling drugs. The unique density of monoclonal antibodies that are ... |